三门峡痤疮价格要多少钱(三门峡做一次狐臭手术多少钱) (今日更新中)

Halloween may be a little spookier this year. A blue moon is set to light up the sky on Oct. 31.Many have heard the phrase, “once in a blue moon.” It refers to something rare, just like this celestial event. NASA says we’re only treated to blue moons every two and a half years, on average.A blue moon is the second full moon in a calendar month, according to modern folklore. And since there are 29 days between moons and most months have 30 or 31 days, having two full moons in a month doesn’t happen often.The next blue moon isn’t expected until Aug 31, 2023, according to MoonGiant.com.Don’t expect a giant blue orb in the sky though. These moons look the same as any other.Before the blue moon on Halloween, another full moon will appeared in the sky on Oct. 1. The first was called the harvest moon and the second will be referred to as the hunter’s moon, according to the Old Farmer’s Almanac.The Farmer’s Almanac says a full moon on Halloween is also rare and only happens every 18 to 19 years. 1010

He's best known for wearing a lot of makeup rocking out with the legendary band KISS, but now, Gene Simmons is embarking on a new business venture.He's the "Chief Evangelist Officer" for a Canadian cannabis company called Invictus M.D. Since Canada doesn't allow celebrity endorsements, the Vancouver-based company actually brought Simmons on board. Their trading letters are even GENE.The company's CEO says their main focus is still medical products, and that's what got Simmons interested. Simmons admits he doesn't use marijuana himself, but after doing research, he went from a skeptic to a believer. RELATED:?Thousands visit Las Vegas for largest marijuana business convention"I saw a 6 year old with epilepsy," Simmons told KTNV television station at the Marijuana Business Convention in Las Vegas. "And from using an ointment it miraculously cured her."As the industry continues to grow, Simmons hopes people will keep an open mind."I urge everyone to do their own research and find out the benefits it is up to you to find the newest information, the newest research," he says. 1124

Half of the coral populations in the Great Barrier Reef off Australia’s coast have been killed off because of warming ocean waters, a new study says.Between 25-30 percent of all marine species rely on coral reefs at some point in their life cycle. The Great Barrier Reef is the world’s largest coral reef, covering nearly 133,000 square miles.It has more than 411 species of hard corals documented, as well as 1,500 species of fish and other animals.Researchers looking at coral populations over 30 years starting in 1995 found there was decline in both shallow and deeper water, and across different species. They said two in particular, branching and table-shaped corals, were especially hard hit in 2016 and 2017 because of record-breaking temperatures.The study finds climate change to be a key driver in reef disturbances that disrupt recovery.“The potential for recovery of older fecund corals is uncertain given the increasing frequency and intensity of disturbance events. The systematic decline in smaller colonies across regions, habitats and taxa, suggests that a decline in recruitment has further eroded the recovery potential and resilience of coral populations,” the researchers note.They also say the coral that spawn the larvae that makes more coral have declined dramatically over large stretches of the reef.“Corals are tremendously resilient because of their capacity to produce millions of babies but they/we desperately need a break from disturbances,” Andreas Dietzel, a professor at the ARC Center and a co-author of the paper, said in an email to the Washington Post. 1600

Heather Locklear was taken to jail after deputies responded to her home Sunday night on a report of domestic violence, and she allegedly attacked a responding police officer.TMZ reports Locklear?became combative toward the officer at her home in Thousand Oaks, California. She was arrested on three counts of misdemeanor battery for the attack.Locklear, known for her roles in "Franklin and Bash," "Melrose Place" and several other TV shows and films, is 56 years old.In years past, she has been arrested on DUI charges. She's had struggles with drug abuse, TMZ says.It is not clear who was in her home when the domestic violence call was made to police. Locklear was expected to post bail, TMZ says.In September 2017, Locklear was hospitalized after being in a crash in Thousand Oaks. 818

Holidays will look different this year for many Americans, with dinners outside, social distancing, or passing on family gatherings altogether. But several companies developing rapid at-home COVID-19 tests are hopeful that won't be the case next year. The goal is to make inexpensive, easy-to-use COVID tests that can deliver results in minutes, just like a pregnancy test. "For people to feel comfortable to associate with friends or family, there needs to be a testing methodology ideally that can be performed at home," said Tony Lemmo, CEO of the manufacturing company BioDot.The company's technology is being used by over 70 manufacturers worldwide making COVID-19 antigen, antibody, and PCR tests. Their automated platforms dispense nanoliter/picoliter amounts of reagent onto the tests accurately and fast.Lemmo says just one of their systems can support the production of roughly 100 million COVID-19 tests per year, helping to make high-volume production possible.“We knew we were going to be called on by customers to manufacture more equipment to provide them the ability to manufacture more tests," said Lemmo. To meet customer demand, BioDot increased staffing and built a new facility, compressing production time from months to weeks. The FDA recently authorized the first rapid at-home test that can deliver results in 30 minutes, eliminating the need for a lab to test the sample. But the molecular single-use test will only be available to patients with a doctor's prescription who are suspected of being infected with COVID-19.Companies developing tests hope the FDA will soon authorize another at-home testing tool: the rapid antigen test.These inexpensive tests provide results within minutes, and companies developing them say millions could be sold without a doctor's referral.“From what we’re hearing, it’s really just a matter of possibly months before there’s at least sufficient data to be able to support an at-home use of a test like an antigen test," said Lemmo.Lemmo says if authorized by the FDA, manufacturers could make millions of these tests in a matter of months. But antigen tests are less accurate, and the FDA wants to ensure they'll be simple enough for people to use at home. There are also concerns over how the data will be reported to health authorities. “I think any at-home testing or massive rollout of a test into the communities needs to be done very carefully and with a lot of education around it," said Clinical Lab Director Melissa Miller. Dr. Miller is a professor of pathology and laboratory medicine at the University of North Carolina Chapel Hill and Medical Director for the Clinical Microbiology Lab for the Medical Center.She worries the inaccuracies of these tests could eventually lead the public to lose trust in all testing. “Even at 98 percent specificity, which is very, very high. That means you’re going to have a false positive two out of every 100. If you started testing a hundred million people, this is millions of people who have a false-positive test," said Dr. Miller. She says this could lead to healthy people isolating and missing work or school unnecessarily, and false-negative results could give people a false sense of security. “These rapid antigen tests were pushed out to skilled nursing facilities; this is a very high-risk patient population. This is actually where you want a very accurate test," said Dr. Miller. She says it’s unclear how well antigen tests detect the virus in asymptomatic patients but agrees more data is needed to figure that out.“It might make more sense for K-12 schools, or even college settings, where there’s less risk for a poor outcome if you have a false positive or a false negative," said Dr. Miller. But with a growing demand for convenient at-home testing, manufacturers are hopeful that in the months ahead, the FDA will soon open the door to new solutions. 3889

来源：资阳报